If the O-selectivity of the condensation is very high in
this strategy using N-unprotected ribonucleoside 3′-phos-
phoramidite units, we can similarly synthesize RNA oligo-
mers containing base-labile functional groups. For example,
it becomes possible to synthesize non-natural aminoacylated
tRNAs4 by solid-phase synthesis or 2′-O-acetoxymethyl
RNAs8 as prodrugs of siRNAs.To examine the selectivity
of condensation using N-unprotected RNA phosphoramidite
units in our activated phosphite method, we performed the
synthesis of 2′-OMe-ApT and 2′-OMe-CpT dimers, as shown
in Scheme 1. The N-unprotected 2′-OMe RNA monomer
be efficiently cleaved by treatment with pyridinium hydro-
chloride as an acidic promoter in the presence of aniline
before the oxidation step. However, this reaction was slow
and in equilibrium with the reverse reaction, as shown in
Figure 1.
Scheme 1. Synthesis of 2′-OMe-ApT (3a) and 2′-OMe-CpT
(3b) Dimers in the Activated Phosphite Method Using HOnBt
Figure 1. Trivalent P-N bond cleavage of a nucleobase using (a)
pyridinium chloride and aniline or (b) HOBt derivatives.
We considered that if HOBt derivatives could be used for
the P-N bond cleavage in place of pyridinium hydrochloride
and aniline, the reverse reaction might be considerably
suppressed. Therefore, we investigated the efficiency of P-N
bond cleavage using HOBt derivatives.
First, we examined this efficiency in the DNA dimer
synthesis of d[ApT] (5a) and d[CpT] (5b). After the coupling
of N-unprotected deoxynucleoside 3′-phosphoramidite de-
rivatives 4a,b5 with dT-loaded HCP 2 in the presence of
benzimidazolium triflate (BIT),12 P-N bond cleavage was
performed by treatment with pyridinum hydrochloride or
HOBt derivatives for 1 min. Subsequently, oxidation of the
resulting phosphite intermediate and release of the desired
dimers from resin were performed by treatment with concd
ammonia. The O-selectivity of each two-step coupling
reaction was evaluated by anion-exchange HPLC analysis
of the reaction mixture obtained, as shown in Table 1.
When the post-treatment was eliminated, the O-selectivities
of condensation in the synthesis of d[ApT] and d[CpT] were
56% and 90%, respectively. The selectivity of the synthesis
of d[ApT] with P-N bond cleavage using pyridinium
hydrogen chloride significantly increased to 96%, but it was
still not enough to synthesize oligonucleotides. The selectivi-
ties in the synthesis of d[ApT] and d[CpT] using HOBt were
similar to that using pyridinium hydrochloride.
building units 1a,b were synthesized by treatment of com-
mercially available N-acylated 2′-OMe RNA phosphoramid-
ite units with methylamine in THF.9 These units reacted with
the hydroxyl group of thymidine on highly cross-linked
polystyrene (HCP) resins10 2 in the presence of 6-nitro-HOBt
(HOnBt) for 10 min at room temperature. The resulting
dimers were released from the resins by treatment with concd
ammonia. The reaction selectivity was estimated by HPLC
analysis of the mixture thus obtained. Unfortunately, these
condensations resulted in very low selectivities of 93% and
95% for 2′-OMe-ApT (3a) and 2′-OMe-CpT (3b), respec-
tively. These results suggested that a new strategy superior
to the activated phosphite method was required for RNA
synthesis without base protection.Therefore, to increase
O-selectivity, we focused on the pioneering study reported
by Gryaznov and Letsinger on the N-unprotected synthesis
of DNA oligomers using a two-step reaction of condensation
and successive P-N bond cleavage.11 In their strategy using
tetrazole or pyridinum chloride as an activator, N-branched
oligonucleotides containing trivalent P-N bonds were gener-
ated as byproducts. They found that these P-N bonds could
To increase the efficiency of P-N bond activation of the
undesired byproducts, we employed two methods using
HOBt derivatives. One involves addition of BIT to the
reaction mixture, based on our previous report that the
coupling efficiency of phosphoramidite units using HOBt
(6) Ohkubo, A.; Kasuya, R.; Sakamoto, K.; Miyata, K.; Nagasawa, H.;
Tsukahara, T.; Maki, Y.; Watanobe, T.; Seio, K.; Sekine, M. Nucleic Acids
Res. 2008, 36, 1952–1964.
(7) Ohkubo, A.; Kasuya, R.; Aoki, K.; Kobori, A.; Taguchi, H.; Seio,
K.; Sekine, M. Bioorg. Med. Chem. 2008, 16, 5345–5351.
(8) Parey, N.; Baraguey, C.; Vasseur, J.-J.; Debart, F. Org. Lett. 2006,
8, 3869–3872.
(11) (a) Gryaznov, S. M.; Letsinger, R. L. J. Am. Chem. Soc. 1991,
113, 5876–5877. (b) Gryaznov, S. M.; Letsinger, R. L. Nucleic Acids Res.
1992, 20, 1879–1882.
(9) Ohkubo, A.; Sakamoto, K.; Miyata, K.; Taguchi, H.; Seio, K.; Sekine,
M. Org. Lett. 2005, 7, 5389–5392.
(12) Hayakawa, Y.; Kataoka, M.; Noyori, R. J. Org. Chem. 1996, 61,
7996–7997.
(10) McCollum, C.; Andrus, A. Tetrahedron Lett. 1991, 32, 4069–4072.
2794
Org. Lett., Vol. 10, No. 13, 2008